There has been increasing emphasis on the importance of the development of self-
regulatory capacities of the individual as the cornerstone of development. The caregivers' …

Tens of thousands of infants are impacted yearly by prenatal opioid exposure. The term
neonatal opioid withdrawal syndrome (NOWS) is now replacing the more familiar term …

Neonates who have had in utero exposures from maternal substance abuse can experience
central nervous system effects of the drugs, including drug toxicity and withdrawal. Neonatal …

Background: The evaluation and management of infants with neonatal abstinence syndrome
(NAS), the constellation of opioid withdrawal specific to newborns, have received renewed …

Background Neonatal abstinence syndrome (NAS) occurs following prenatal opioid
exposure. It is characterized by signs and symptoms indicating central nervous system …

Background Neonatal abstinence syndrome (NAS) includes an array of symptoms impacting
opioid-exposed newborns (OEN) owing to postnatal withdrawal from in utero substance …

The opioid epidemic has brought with it an increasing focus on the incidence of Neonatal
Abstinence Syndrome (NAS)(also known as Neonatal Opioid Withdrawal Syndrome) in …

Use and abuse of prescription opioids and concomitant increase in Neonatal Abstinence
Syndrome (NAS), a condition that may lead to protracted pharmacological treatment in more …

Neonates exposed prenatally to opioids will often develop a collection of withdrawal signs
known as neonatal abstinence syndrome (NAS). The incidence of NAS has substantially …

The prevalence of newborns with neonatal abstinence syndrome (NAS) is rising sharply. To
respond to this crisis, our institution re-examined our policies and procedures regarding our …